Breast cancer that spread to a rare spot deep in the brain
Original title: Case report of invasive lobular carcinoma with pineal metastasis.
How far along is this research?
- Lab cells
- Animals
- Review
- Tested in people
This was tested in people. That is the most reliable kind of research we share.
This is a report about one patient, not a study, and it does not test a new treatment.
The short version
Doctors report on one woman whose breast cancer spread to a small gland deep in her brain.
What was studied. This is a report about one patient. She was a 59-year-old woman with a kind of breast cancer called invasive lobular carcinoma. Doctors wrote down what happened to her and how they treated her.
What they found. She had chemotherapy, then surgery, then radiation and hormone treatment. Nine months after surgery the cancer came back in her bones, and one month later she had headaches and double vision. A brain scan showed spots in three areas, including a small gland deep in the brain called the pineal gland. Doctors took a small tissue sample, and it showed the cancer had changed into a different type called triple negative. She was then treated with radiation to the whole brain plus an extra dose to the spot, followed by chemotherapy.
What this means, and what it doesn't
What it could mean: If breast cancer shows up in an unusual place in the brain, taking a small tissue sample can be worth it. Cancer can change its type when it spreads. Knowing that change can point doctors toward a different treatment.
What it doesn't mean: This does not mean a new treatment has been found. It is a report about one person, not a study that compared treatments in a group. Nothing here shows that this approach works better for anyone else. It is not a promise of a cure. The tests and treatments described are already used in care, so this is a lesson from one case, not a new option to ask for.
Source: PubMed, July 27, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.